| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-10 19:33:11 UTC |
|---|
| Updated at | 2024-09-10 19:33:12 UTC |
|---|
| NP-MRD ID | NP0334693 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Azythromycin |
|---|
| Description | Azythromycin belongs to the class of organic compounds known as aminoglycosides. These are molecules or a portion of a molecule composed of amino-modified sugars. Azithromycin is an azalide, a subclass of macrolide antibiotics. Azythromycin is a very strong basic compound (based on its pKa). In humans, azythromycin is involved in azithromycin action pathway. Azithromycin is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring, thus making the lactone ring 15-membered. Azithromycin is sold under the brand names Zithromax ("Zmax") and Sumamed, and is one of the world's best-selling antibiotics. Azithromycin is used to treat certain bacterial infections, most often bacteria causing middle ear infections, tonsillitis, throat infections, laryngitis, bronchitis, pneumonia and sinusitis. It is also effective against certain sexually transmitted infectious diseases, such as non-gonococcal urethritis and cervicitis. |
|---|
| Structure | CC[C@@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@@H](C)O2)[C@@H](C)[C@H](O[C@H]2O[C@@H](C)C[C@H]([C@@H]2O)N(C)C)[C@@](C)(O)C[C@H](C)CN(C)[C@@H](C)[C@@H](O)[C@]1(C)O InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,29-,30-,31+,32+,33-,35+,36-,37-,38+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Azithramycine | HMDB | | Azithromycin | HMDB | | Azithromycin (aids initiative) | HMDB | | Azithromycin dihydrate | HMDB | | Azithromycin plus tumor necrosis factor | HMDB | | Azithromycin sterile | HMDB | | Azithromycine | HMDB | | N,N-Dimethyl-4-amino-benzaldehyde | HMDB | | ZIT | HMDB | | Zithromax | HMDB | | Azithromycin monohydrate | MeSH | | Goxal | MeSH | | Azithromycin pfizer brand | MeSH | | Dihydrate, azithromycin | MeSH | | Pfizer brand OF azithromycin dihydrate | MeSH | | Sumamed | MeSH | | Toraseptol | MeSH | | Zentavion | MeSH | | Monohydrate, azithromycin | MeSH | | Azadose | MeSH | | Bayer brand OF azithromycin dihydrate | MeSH | | Funk brand OF azithromycin dihydrate | MeSH | | Pharmacia brand OF azithromycin dihydrate | MeSH | | Mack brand OF azithromycin dihydrate | MeSH | | Pfizer brand OF azithromycin | MeSH | | Azitrocin | MeSH | | Ultreon | MeSH | | Lesvi brand OF azithromycin dihydrate | MeSH | | Vinzam | MeSH | | Vita brand OF azithromycin dihydrate | MeSH | | Zitromax | MeSH |
|
|---|
| Chemical Formula | C38H72N2O12 |
|---|
| Average Mass | 748.9845 Da |
|---|
| Monoisotopic Mass | 748.50853 Da |
|---|
| IUPAC Name | (2S,3S,4R,5S,8S,10S,11S,12R,13S,14R)-11-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-2-ethyl-3,4,10-trihydroxy-13-{[(2S,4S,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one |
|---|
| Traditional Name | zithromax IV |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@@H](C)O2)[C@@H](C)[C@H](O[C@H]2O[C@@H](C)C[C@H]([C@@H]2O)N(C)C)[C@@](C)(O)C[C@H](C)CN(C)[C@@H](C)[C@@H](O)[C@]1(C)O |
|---|
| InChI Identifier | InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,29-,30-,31+,32+,33-,35+,36-,37-,38+/m0/s1 |
|---|
| InChI Key | MQTOSJVFKKJCRP-HHZDEWPHSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, 100%_DMSO, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminoglycosides. These are molecules or a portion of a molecule composed of amino-modified sugars. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Aminoglycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminoglycoside core
- Macrolide
- Glycosyl compound
- O-glycosyl compound
- Monosaccharide
- Oxane
- Tertiary alcohol
- 1,2-aminoalcohol
- Amino acid or derivatives
- Carboxylic acid ester
- Lactone
- Secondary alcohol
- Tertiary amine
- Tertiary aliphatic amine
- Oxacycle
- Acetal
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Polyol
- Azacycle
- Ether
- Dialkyl ether
- Carboxylic acid derivative
- Organic nitrogen compound
- Alcohol
- Carbonyl group
- Organonitrogen compound
- Organopnictogen compound
- Amine
- Organic oxide
- Hydrocarbon derivative
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|